Status:
COMPLETED
Cutaneous Silent Period Assessment in Primary Sjögren's Syndrome
Lead Sponsor:
Marmara University
Conditions:
Small Fiber Neuropathy
Primary Sjögren Syndrome
Eligibility:
All Genders
18-65 years
Brief Summary
Primary Sjögren's syndrome (pSS) is a chronic, immune-mediated inflammatory disease mainly characterized by exocrine gland involvement. Beyond the wide heterogeneity in clinical presentation, neurolog...
Eligibility Criteria
Inclusion
- Being between the ages of 18-65
- For the patient group, patients followed up in accordance with the 2016 ACR/EULAR primary Sjögren's Syndrome classification criteria
Exclusion
- Any comorbidities that may cause neuropathy
- Any drugs that may cause neuropathy
- Chronic alcohol consumption
- A history of disease that may affect the central nervous system
Key Trial Info
Start Date :
January 4 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 28 2022
Estimated Enrollment :
72 Patients enrolled
Trial Details
Trial ID
NCT05380804
Start Date
January 4 2021
End Date
February 28 2022
Last Update
May 19 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Marmara University Pendik Education and Research Hospital
Istanbul, Pendik, Turkey (Türkiye), 34899